A citation-based method for searching scientific literature

Stephanie Wrobel Goldberg, Stephen David Silberstein. CNS Drugs 2015
Times Cited: 49







List of co-cited articles
482 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Marcelo E Bigal, Lars Edvinsson, Alan M Rapoport, Richard B Lipton, Egilius L H Spierings, Hans-Christoph Diener, Rami Burstein, Pippa S Loupe, Yuju Ma, Ronghua Yang,[...]. Lancet Neurol 2015
177
36


Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel. Lancet Neurol 2014
252
30

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Marcelo E Bigal, David W Dodick, Alan M Rapoport, Stephen D Silberstein, Yuju Ma, Ronghua Yang, Pippa S Loupe, Rami Burstein, Lawrence C Newman, Richard B Lipton. Lancet Neurol 2015
192
30

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman,[...]. Lancet Neurol 2014
253
28

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
Hong Sun, David W Dodick, Stephen Silberstein, Peter J Goadsby, Uwe Reuter, Messoud Ashina, Joel Saper, Roger Cady, Yun Chon, Julie Dietrich,[...]. Lancet Neurol 2016
240
28

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
Jes Olesen, Hans-Christoph Diener, Ingo W Husstedt, Peter J Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M Lesko. N Engl J Med 2004
877
24

Fremanezumab for the Preventive Treatment of Chronic Migraine.
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
342
24

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
H C Diener, D W Dodick, S K Aurora, C C Turkel, R E DeGryse, R B Lipton, S D Silberstein, M F Brin. Cephalalgia 2010
575
20

Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Eva Cernuda-Morollón, Davinia Larrosa, César Ramón, Juan Vega, Pablo Martínez-Camblor, Julio Pascual. Neurology 2013
232
20


Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
Jakob Møller Hansen, Anne Werner Hauge, Jes Olesen, Messoud Ashina. Cephalalgia 2010
277
18


Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Tony W Ho, Michel D Ferrari, David W Dodick, Vince Galet, James Kost, Xiaoyin Fan, Heather Leibensperger, Samar Froman, Christopher Assaid, Christopher Lines,[...]. Lancet 2008
416
18


Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.
Sajedeh Eftekhari, Christopher A Salvatore, Sara Johansson, Tsing-Bau Chen, Zhizhen Zeng, Lars Edvinsson. Brain Res 2015
159
18

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
373
18

A Controlled Trial of Erenumab for Episodic Migraine.
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
420
18


BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study.
Hans-Christoph Diener, Piero Barbanti, Carl Dahlöf, Uwe Reuter, Julia Habeck, Jana Podhorna. Cephalalgia 2011
164
16

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
S K Aurora, D W Dodick, C C Turkel, R E DeGryse, S D Silberstein, R B Lipton, H C Diener, M F Brin. Cephalalgia 2010
525
16

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.
Ana Recober, Adisa Kuburas, Zhongming Zhang, John A Wemmie, Michael G Anderson, Andrew F Russo. J Neurosci 2009
130
16

BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
Ronald Marcus, Peter J Goadsby, David Dodick, David Stock, George Manos, Tanya Z Fischer. Cephalalgia 2014
176
16

Calcitonin gene-related peptide: physiology and pathophysiology.
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
573
16

Pathophysiology of migraine.
Daniela Pietrobon, Michael A Moskowitz. Annu Rev Physiol 2013
388
14

Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
Dawn C Buse, Aubrey N Manack, Kristina M Fanning, Daniel Serrano, Michael L Reed, Catherine C Turkel, Richard B Lipton. Headache 2012
287
14

Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.
Marcelo E Bigal, Rafael Escandon, Michele Bronson, Sarah Walter, Maria Sudworth, John P Huggins, Pamela Garzone. Cephalalgia 2014
62
14

Adherence to oral migraine-preventive medications among patients with chronic migraine.
Zsolt Hepp, David W Dodick, Sepideh F Varon, Patrick Gillard, Ryan N Hansen, Emily B Devine. Cephalalgia 2015
211
14

Migraine prevalence, disease burden, and the need for preventive therapy.
R B Lipton, M E Bigal, M Diamond, F Freitag, M L Reed, W F Stewart. Neurology 2007
14

Therapeutic antibodies against CGRP or its receptor.
Marcelo E Bigal, Sarah Walter, Alan M Rapoport. Br J Clin Pharmacol 2015
74
14

CGRP may play a causative role in migraine.
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
664
14

Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor.
Licheng Shi, Sonya G Lehto, Dawn X D Zhu, Hong Sun, Jianhua Zhang, Brian P Smith, David C Immke, Kenneth D Wild, Cen Xu. J Pharmacol Exp Ther 2016
143
14

Wiping Out CGRP: Potential Cardiovascular Risks.
Antoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, Michel D Ferrari. Trends Pharmacol Sci 2016
131
14

Pathophysiology of Migraine: A Disorder of Sensory Processing.
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
740
14

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Stephen D Silberstein, Richard B Lipton, David W Dodick, Frederick G Freitag, Nabih Ramadan, Ninan Mathew, Jan L Brandes, Marcelo Bigal, Joel Saper, Steven Ascher,[...]. Headache 2007
335
12

Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study.
Marcelo E Bigal, Daniel Serrano, Dawn Buse, Ann Scher, Walter F Stewart, Richard B Lipton. Headache 2008
486
12

Global prevalence of chronic migraine: a systematic review.
J L Natoli, A Manack, B Dean, Q Butler, C C Turkel, L Stovner, R B Lipton. Cephalalgia 2010
390
12

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Marcelo E Bigal, Daniel Serrano, Michael Reed, Richard B Lipton. Neurology 2008
341
12



Anti-CGRP monoclonal antibodies in migraine: current perspectives.
Maria Adele Giamberardino, Giannapia Affaitati, Martina Curto, Andrea Negro, Raffaele Costantini, Paolo Martelletti. Intern Emerg Med 2016
37
16

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
David J Hewitt, Sheena K Aurora, David W Dodick, Peter J Goadsby, Yang Joy Ge, Robert Bachman, Donna Taraborelli, Xiaoyin Fan, Christopher Assaid, Christopher Lines,[...]. Cephalalgia 2011
200
12

Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP.
Marcelo E Bigal, Sarah Walter, Michele Bronson, Abbas Alibhoy, Rafael Escandon. Cephalalgia 2014
45
13


Calcitonin gene-related peptide and migraine.
Nazia Karsan, Peter J Goadsby. Curr Opin Neurol 2015
51
12


Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Tony W Ho, Kathryn M Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J Goadsby, David Michelson. Neurology 2014
166
12

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
Lanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini. Clin Pharmacol Drug Dev 2017
47
12

Blocking CGRP in migraine patients - a review of pros and cons.
Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson, Antoinette Maassen Van Den Brink. J Headache Pain 2017
147
12

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
H-C Diener, G Bussone, J C Van Oene, M Lahaye, S Schwalen, P J Goadsby. Cephalalgia 2007
375
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.